A pilot study to assess the use of protein a immunoadsorption for chronic dilated cardiomyopathy

Journal of Clinical Apheresis

Volumn 22, Issue 4, 2007, Pages 210-214

  Cooper, Leslie T ^a   Belohlavek, Marek ^a   Korinek, Josef ^a   Yoshifuku, Shiro ^a   Sengupta, Partho P ^a   Burgstaler, Edwin A ^a   Winters, Jeffrey L ^a  

^a MAYO CLINIC   (United States)

Author keywords

Anticardiac antibodies; Dilated cardiomyopathy; Immunoadsorption; Myocarditis

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G3; PROTEIN A;

ADULT; APHERESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG EFFECT; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; FEVER; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOPROTEINEMIA; HYPOTENSION; IMMUNOADSORPTION; MALE; NAUSEA; PARESTHESIA; QUALITY OF LIFE; QUESTIONNAIRE; SKIN TINGLING; WEIGHT GAIN;

CARDIOMYOPATHY, DILATED; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSORBENT TECHNIQUES; MALE; PILOT PROJECTS; QUALITY OF LIFE; STAPHYLOCOCCAL PROTEIN A;

EID: 34548232245     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20130     Document Type: Article

References (25)

1. Taylor D, Edwards L, Boucek M, Trulock E, Waltz D, Keck B, Hertz M. Registry of the International Society for Heart and Lung Transplantation: Twenty-third Official Adult Heart Transplantation Report. J Heart Lung Transplant 2006;25:869-879.
2. Maisch B, Ristic AD, Hufnagel G, Pankuweit S. Pathophysiology of viral myocarditis: the role of humoral immune response. Cardiovasc Pathol 2002;11:112-122.
3. Jahns R, Boivin V, Kein L, Triebel S, Angermann C, Ertl G, Lohse M. Direct evidence for a β-1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 2004;113:1419-1429.
4. Bachmeier K, Neu N, da la Maza L, Pal S, Hessel A, Penninger J. Chlamydia infections and heart disease linked through anti-genic mimicry. Science 1999;283:1335-1339.
5. Wolff P, Kuhl U, Schultheiss H. Laminin distribution and auto-antibodies to laminin in dilated cardiomyopathy and myocarditis. Am Heart J 1989;117:1303-1309.
6. Schulze K, Becker BF, Schultheiss HP. Antibodies to the ADP/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo. Circ Res 1989;64:179-192.
7. Schulze K, Becker BF, Schauer R, Schultheiss HP. Antibodies to ADP-ATP carrier-an autoantigen in myocarditis and dilated cardiomyopathy-impair cardiac function. Circulation 1990;81: 959-969.
8. Lauer B, Padberg K, Schultheiss HP, Strauer BE. Autoantibodies against human ventricular myosin in sera of patients with acute and chronic myocarditis. J Am Coll Cardiol 1994;23:146-153.
9. Warraich RS, Noutsias M, Kasac I, Seeberg B, Dunn MJ, Schultheiss HP, Yacoub MH, Kuhl U. Immunoglobulin G3 cardiac myosin autoantibodies correlate with left ventricular dysfunction in patients with dilated cardiomyopathy: immunoglobulin G3 and clinical correlates. Am Heart J 2002;143:1076-1084.
10. Staudt A, Bohm M, Knebel F, Grosse Y, Bischoff C, Hummel A, Dahm J, Borges A, Jochmann N, Wernecke K, Wallukat G, Baumann G, Felix S. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation 106 2002;19:2448-2453.
11. Wallukat G, Reinke P, Dorffel W, Luther H, Bestvater K, Felix SB, Baumann G. Removal of autoantibodies in dilated cardiomyopathy by immunoabsorbtion. Intl J Cardiol 1996;54:191-195.
12. Dorffel W, Felix S, Wakllukat G, Brehme S, Bestvater K, Hofmann T, Kleber FX, Baumann G, Reinke P. Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy. Circulation 1997;95:1994-1997.
13. Wallukat G, Müller J, Hetzer R. Specific removal of β1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy (letter). N Engl J Med 2002;347:1806.
14. Staudt A, Schaper F, Stangl V, Plagemann A, Bohnm M, Merkel K, Wallukat G, Wernecke KD, Stangl K, Baumann G, Felix SB. Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation 2001;103:2681-2686.
15. Felix SB, Staudt A, Dorffel W, Stangl V, Merkel K, Pohl M, Docke WD, Morgera S, Neumayer HH, Wernecke KD, Wallukat G, Stangl K, Baumann G. Hemodynamic effects of immunoadsorbtion and subsequent immunoglobulin substitution in dilated cardiomyopathy: three month results from a randomized study. J Am Coll Cardiol 2000;35:1590-1598.
16. Staudt A, Hummel A, Ruppert J, Dorr M, Trimpert C, Birkenmeier K, Krieg T, Staudt Y, Felix S. Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study. Am Heart J 2006;152:712.e1-712.e6.
17. Cheitlin M, Alpert J, Armstrong W, Augrigemma G, Beller G, Bierman F, Davidson T, Davis J, Douglas P, Gillman L. ACC/AHA guidelines for the application of echocardiography. Circulation 1997;95:1686-1744.
18. Korinek J, Wang J, Sengupta P, Miyazaki C, Kjaergaard J, McMahon E, Abraham T, Belohlavek M. D Strain-a doppler independent ultrasound method for quantitation of regional deformation: validation in-vitro and in-vivo. J Am Soc Echocardiogr 2005;18:1247-1253.
19. Korinek J, Kjaergaard J, Sengupta PP, Yoshifuku S, McMahon EM, Cha SS, Khandheria BK, Belohlavek M. High spatial resolution speckle tracking improves accuracy of 2-dimensional strain measurements: an update on a new method in functional echocardiography. J Am Soc Echocardiogr 2007;20:165-170.
20. Rector T, Kubo S, Cohn J. Patients' self-assessment of their congestive heart failure, Part 2: content, reliability and validity of a new measure, the Minnesota Living with Heart Failure questionnaire. Heart Failure 1987;Oct/Nov:198-209.
21. Rector T, Cohn J. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group [Clinical Trial. Multicenter Study. Randomized Controlled Trial. Research Support, Non-U.S. Gov't]. Am Heart J 1992;124:1017-1025.
22. Rector T, Kubo S, Cohn J. Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol 1993;71:1106-1107.
23. Gullestad L, Aass H, Fjeld J, Wikeby L, Andreassen A, Ihlen H, Simonsen S, Kjekshus J, Nitter-Hauge S, Ueland T, Lien E, Froland S, Aukrust P. Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure. Circulation 2001;103:220-225.
24. Schmaldienst S, Mullner M, Goldammer A, Spitzauer S, Banyai S, Horl W, Derfler K. Intravenous immunoglobulin application following immunoadsorption: benefit or risk in patients with autoimmune diseases? Rheumatology (Oxford) 2001;40:513-521.
25. Schimke I, Muller JJ, Priem F, Kuruse I, Schon B, Stein J, Kunze R, Wallukat G, Hetzer R. Decreased oxidative stress in patients with idiopathic dilated cardiomyopathy one year after immuno-globulin adsorption. J Am Coll Cardiol 2002;38:178-183.